Bluestone Center for Clinical Research. New York University College of Dentistry
New York, 10010-4086, United States
NCT Number: NCT03753464
The aim of this pilot, exploratory, single blind clinical trial is to evaluate the epigenetic changes associated with peri-implantitis.
Looking for future studies?
Notify Me20 year–90 year
All sexes
Observational
New York, 10010-4086, United States
Twenty patients will be voluntarily enrolled in two groups: 10 healthy participants, and 10 participants with peri-implantitis. Periodontal and peri-implant clinical and radiographic measurements, as well as body mass index, medical and dental history will be recorded within the following timelines: at baseline (for both groups), and 6 months after baseline for the peri-implantitis group only. At baseline, gingival biopsies and blood will be harvested from: a) healthy gingival sites during either surgical removal of wisdom teeth or gingivoplasty, in the healthy group; and, b) from a peri-implantitis site during surgical treatment of peri-implantitis, and when possible, from a healthy gingival site within the same participant, in the peri-implantitis group. After harvesting of biopsies, peri-implantitis subjects will be re-evaluated 6 months after treatment. During the 6-month visit, if a second surgical treatment of peri-implantitis in the same implant treated at baseline is indicated as standard of care of the participant, a new gingiva biopsy and blood will be collected. Gingival biopsies and blood collected from each participant will be used to perform DNA methylation analysis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
General Inclusion Criteria:
Healthy Periodontal Subjects Inclusion Criteria:
In addition to the general inclusion criteria, a healthy periodontal subject must meet all of the following criteria:
Peri-implantitis Subjects Inclusion Criteria:
In addition to the general inclusion criteria, a PIT subject must meet all of the following criteria:
Exclusion criteria
General Exclusion Criteria:
Periodontally Healthy Subjects Exclusion:
In addition to the general exclusion criteria, subjects allocated to the healthy group who meet any of the following criteria will be excluded from participation in this study:
Peri-implantitis subjects Exclusion:
In addition to the general exclusion criteria, subjects allocated to the PIT group who meet any of the following criteria will be excluded from participation in this study:
Gingival and blood samples will be collected.
Time frame: 6 months
Gingival and blood samples collected from healthy subjects and subjects with peri-implantitis will be used to determinate epigenetic signatures associated with peri-implantitis.
Time frame: 6 months
Samples collected from patients with peri-implantitis will be used to determinate epigenetic signatures associated response to treatment peri-implantitis at 6 months. (Gingival biopsies and blood collected to perform DNA methylation analysis)
Time frame: 6 months
A visual analog scale (VAS) will be used to evaluate patient's pain/discomfort, esthetic satisfaction, and the subjects' overall satisfaction at baseline and at 6 months.
Time frame: 6 months
Oral Health Impact Profile-14 (OHIP-14) assessed at baseline and at 6 months.
Time frame: 6 months
Peri-implant pocket depths (PPD) will be assessed at baseline and 6 month after surgery.
Time frame: 6 months
Peri-implant BOP (in percentage) will be assessed at baseline and 6 month after surgery.
Time frame: 6 months
Percentage of peri-implant pocket closure will be assessed at at to 6 month after surgery.
Time frame: 6 months
Mean crestal bone level change around the implants will be determined by periapical radiographs of mesial and distal bone levels from baseline to 6 months surgery.
Time frame: 6 months
Soft tissue levels assessed at baseline and 6 months post-surgery in implants with peri-implantitis.
Time frame: 6 months
Number of post-operative surgical site infections from surgery to 6 months.
Time frame: 6 months
Number of post-operative complications from surgery to 6 months.
NYU College of Dentistry
Other
The Role of Functional Epigenetic Modifications in Peri-Implantitis: A Pilot Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06849856
Mouth Diseases, Peri-Implantitis
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07379892
Mouth Diseases, Peri-Implantitis
Aydin, Turkey (Türkiye)
View Trial DetailsNCT06695559
Mouth Diseases, Peri-Implantitis
Thessaloniki, Greece
View Trial DetailsNCT05811390
Mouth Diseases, Peri-Implantitis
Porto, Porto District, Portugal
View Trial Details